$EBS

Emergent BioSolutions Inc.

NYSE · Healthcare · Pharmaceutical Preparations · Gaithersburg, MD

EBS chart

What traders are saying about $EBS

Latest posts

Emergent BioSolutions Inc. news

Emergent BioSolutions Inc. key financials

USD2025202420232022
Revenue$742.9M$1.04B$1.05B–
Net income$52.6M-$190.6M-$760.5M-$211.6M
Diluted EPS$0.93$-3.60$-14.85$-4.22
Total assets (year end)$1.32B$1.39B$1.82B$3.17B
Cash and equivalents (year end)$205.4M$99.5M$111.7M$642.6M

Calendar-year figures as reported to the SEC in XBRL filings.

Recent SEC filings

About Emergent BioSolutions Inc.

Ticker
EBS (NYSE)
Industry
Pharmaceutical Preparations
Headquarters
Gaithersburg, MD
Incorporated in
DE
Fiscal year end
December 31
SEC CIK
1367644

Frequently asked questions

What exchange is Emergent BioSolutions Inc. listed on?

Emergent BioSolutions Inc. trades on the NYSE under the ticker symbol EBS.

What industry is Emergent BioSolutions Inc. in?

Emergent BioSolutions Inc. is classified by the SEC under "Pharmaceutical Preparations", part of the Healthcare sector on StockTweeting.

Where is Emergent BioSolutions Inc. headquartered?

Emergent BioSolutions Inc.'s business address on file with the SEC is in Gaithersburg, MD.

When does Emergent BioSolutions Inc.'s fiscal year end?

Emergent BioSolutions Inc.'s fiscal year ends on December 31.

How much revenue did Emergent BioSolutions Inc. report?

Emergent BioSolutions Inc. reported $742.9M in revenue for calendar year 2025, according to its SEC filings.